Levoftyal

Levofloxacin, the active ingredient in Levoftyal, is a fluoroquinolone presented as an ophthalmic solution for ocular use. It is employed to treat bacterial infections of the eye in adult patients under medical supervision.

GNH USA supplies Levoftyal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levoftyal is a fluoroquinolone antibiotic indicated for bacterial infections of the eye. It is applied directly to the ocular surface to eradicate susceptible pathogens.

- Bacterial conjunctivitis: reduces bacterial load and accelerates symptom relief. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Post‑operative endophthalmitis: prevents or treats intra‑ocular infection after surgery.

Levoftyal may cause local and systemic adverse reactions. Most events are mild and resolve after discontinuation.

Common Side Effects: - Ocular burning or stinging sensation. - Redness of the conjunctiva. - Transient blurred vision. - Increased tearing or discharge. - Foreign‑body feeling in the eye. - Mild eyelid edema.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Corneal ulceration or perforation. - Significant intra‑ocular inflammation. - Systemic hypersensitivity (e.g., rash, fever).

Levoftyal should be used with caution and under professional guidance.

- Allergy to fluoroquinolones: discontinue immediately if hypersensitivity is observed. - Use only for the prescribed indication: avoid off‑label ocular use. - Contact lens wearers: remove lenses during treatment and until symptoms resolve. - Corneal epithelial defects: avoid use on compromised corneal surfaces. - Monitor for signs of severe ocular inflammation or systemic allergic response. - Store at room temperature: keep in the original container, protect from light and moisture.

Levoftyal may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent systemic fluoroquinolones: risk of additive toxicity. - Topical corticosteroids: may delay wound healing and increase infection risk.

Moderate Interactions (Monitor Closely): - Other ophthalmic antibiotics: assess for antagonistic effects. - Non‑steroidal anti‑inflammatory eye drops: monitor for delayed corneal recovery. - Herbal supplements such as ginkgo biloba: may potentiate bleeding risk if systemic absorption occurs. - Antacids or multivitamins containing divalent cations: unlikely with ocular use but note systemic exposure.